|
|
Volumn 13, Issue 6, 2002, Pages 956-964
|
|
Localized unresectable neuroblastoma: Results of treatment based on clinical prognostic factors
a
|
|
Author keywords
Prognostic factors; Treatment; Unresectable neuroblastoma
|
|
Indexed keywords
(3 IODOBENZYL)GUANIDINE I 131;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DEFEROXAMINE;
DOXORUBICIN;
ETOPOSIDE;
FERRITIN;
LACTATE DEHYDROGENASE;
NEURON SPECIFIC ENOLASE;
ONCOPROTEIN;
PEPTICHEMIO;
TENIPOSIDE;
THIOTEPA;
VANILMANDELIC ACID;
VINCRISTINE;
ADOLESCENT;
ARTICLE;
CANCER GROWTH;
CANCER LOCALIZATION;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CAUSE OF DEATH;
CHILD;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
FEMALE;
FOLLOW UP;
GENE AMPLIFICATION;
HIGH RISK PATIENT;
HUMAN;
INFANT;
INOPERABLE CANCER;
LACTATE DEHYDROGENASE BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS;
NEUROBLASTOMA;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
SIDE EFFECT;
STATISTICAL ANALYSIS;
TREATMENT FAILURE;
URINARY EXCRETION;
ADJUVANT THERAPY;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
MORTALITY;
NEEDLE BIOPSY;
NEWBORN;
PATHOLOGY;
PRESCHOOL CHILD;
PROPORTIONAL HAZARDS MODEL;
RETROSPECTIVE STUDY;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY, NEEDLE;
CHILD;
CHILD, PRESCHOOL;
COMPARATIVE STUDY;
CYCLOPHOSPHAMIDE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMAN;
INFANT;
INFANT, NEWBORN;
MALE;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
NEUROBLASTOMA;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
SUPPORT, NON-U.S. GOV'T;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VINCRISTINE;
HUMANS;
|
|
EID: 0035990125
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf165 Document Type: Article |
|
Times cited : (32)
|
|
References (21)
|
